Viewing Study NCT06586593


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-22 @ 2:27 PM
Study NCT ID: NCT06586593
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module